Login
$RFL
$1.21 -$0.03 (2.42%) Close

Company Executives

Management Team

From the 10-K annual report
Officer Age In this role Joined 2025 pay Source
Howard S. Jonas
Chief Executive Officer
Not stated Not stated Not stated $294,000
David Polinsky
Chief Financial Officer
Not stated Not stated Not stated $527,353
Joshua Fine
Chief Operating Officer
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

We could not read this board reliably

Rather than show a list that might be wrong, we show nothing. The board is in the proxy filed Nov 18, 2025.

Read the board in the proxy
7 disclosed in the proxy filed Nov 18, 2025
IDT Corporation
IDT, for which Howard S. Jonas serves as the Chairman of the Board
$275,323
Fiscal 2025

Transition Services Agreement under which IDT provides administrative and legal services to the Company

With the Company Open in proxy
IDT Corporation
$370,000
Fiscal 2025

IDT leased approximately 3,600 square feet of office space from the Company in Jerusalem and paid office rent

With the Company Open in proxy
Howard S. Jonas
Chief Executive Officer, President, Executive Chairman and Chairman of the Board
Amount not stated

Standby Purchase Agreement under which the Company sold 16,400,770 shares of Class B common stock to the Standby Purchaser at $1.28 per share in connection with the Rights Offering

With the Company Open in proxy
Cornerstone Pharmaceuticals, Inc.
Howard S. Jonas and David Polinsky own an interest in Cornerstone Pharma and Howard S. Jonas serves as Chairman of the Board of Cornerstone Pharma
$200,000
Fiscal 2025

Company provided administrative, finance, accounting, tax and legal services to Cornerstone Pharma, which owed the Company

With the Company Open in proxy
Chai Inspiration Ventures LLC
limited liability company owned by various members of Howard S. Jonas’ family
$500,000

Company invested in Nina Medical Ltd. in exchange for Seed Preferred Shares and a warrant; Chai Inspiration Ventures LLC holds about 20% of the Seed Preferred Shares and a warrant

With Nina Medical Ltd. Open in proxy
Sam Beyda
Howard Jonas’ son-in-law who served as Chief Executive Officer and a Director of Day Three Labs, Inc.
$175,000
Fiscal 2025

Salary and bonus paid by the Company to Sam Beyda

Sam Beyda
Howard Jonas’ son-in-law who served as Chief Executive Officer and a Director of Day Three Labs, Inc.
Amount not stated
January 13, 2025

Grant of 15,000 restricted shares of Class B common stock, later forfeited when he left the Company

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support